Background More than half of patients with polymyalgia rheumatica have a relapse during tapering of glucocorticoid therapy. Previous studies have suggested that interleukin-6 blockade may be ...
DelveInsight's " Polymyalgia Rheumatica Market Insights, Epidemiology, and Market Forecast - 2034" report delivers an in-depth understanding of the Polymyalgia Rheumatica, historical and forecasted ...
PORTLAND, Ore.--(BUSINESS WIRE)--Sparrow Pharmaceuticals today announced that it presented new data from its ongoing Phase 2 clinical trial of its HSD-1 inhibitor, clofutriben (referred to SPI-62 in ...
Polymyalgia Rheumatica (PMR) is one of those conditions that often goes undiagnosed for months or even years. Waiting too long to start treatment can make the disorder worse, which is why recognizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results